Neonatal thrombosis: causes, pathogenesis, treatment features
https://doi.org/10.21508/1027-4065-2021-66-2-21-28
Abstract
Neonatal thrombosis occurs in 2.4–7% of newborns, more than half of them are premature. The syndrome is characterized by limb edema, pain syndrome, hyperthermia of the extremities, abdominal effusion, hematuria and other symptoms. Both the physiological characteristics of the hemostasis system of the newborn, and the state of health of the mother and external factors are considered the causes of neonatal thrombosis. For the moment thrombolytic therapy, heparins and, in critical cases, thrombectomy are used to treat neonatal thrombosis. Particular attention is paid to drugs which have a positive effect in the treatment of adults, such as dabigatran, danaparoid, hirudin, argatroban, apixaban, rivaroxaban and sodium fondaparinux. Development of convenient forms of anticoagulants, determination of age- and weight-dependent doses, study of the effect of thrombolytic drugs used in adult practice on the newborn’s body, as well as confirmation of the effectiveness of the recombinant tissue plasminogen activator – these are the questions that need to be resolved to reduce the risk of developing neonatal blood clots and their severe consequences.
About the Authors
A. V. Bairashevskaya
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Moscow
O. V. Kytko
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Moscow
References
1. Shaik M., Patel D., Mihir B., Chan A.K.C., Paes B. Epidemiology, Diagnosis and Management of Neonatal Thrombosis. Blood 2019; 134: 3656. DOI: 10.1182/blood-2019-129914
2. Szpecht D., Szymankiewicz M., Nowak I., Gadzinowski J Intraventricular hemorrhage in neonates born before 32 weeks of gestation-retrospective analysis of risk factors. Childs Nerv Syst 2016; 32: 1399–1404. DOI: 10.1007/s00381-016-3127-x
3. Bikdeli B., Jiménez D., Hawkins M., Ortíz S., Prandoni P., Brenner B. et al. Rationale, design and methodology of the computerized registry of patients with venous thromboembolism (RIETE). Thromb Haemost 2018; 118(1): 214–224. DOI: 10.1160/TH17-07-0511
4. Sirachainan N., Limrungsikul A., Chuansumrit A., Nuntnarumit P., Thampratankul L., Wangruangsathit S. et al. Incidences, risk factors and outcomes of neonatal thromboembolism, J Matern Fetal Neonatal Med 2018; 31:347–351. DOI: 10.1080/14767058.2017.1285892
5. Haley K.M. Neonatal Venous Thromboembolism. Front Pediatr 2017; 5: 136–142. DOI: 10.3389/fped.2017.00136
6. Sewell E.K., Forman K.R., Wong E.C.C., Gallagher M., Luban N.L.C., Massaro A.N. Thromboelastography in term neonates: an alternative approach to evaluating coagulopathy. Arch. Dis. Child Fetal Neonatal Ed 2017; 102: F79–F84. DOI: 10.1136/archdischild-2016-310545
7. Roshdy E.A. White Blood Cells and Platelets Indices as a Prognostic Factor in Neonatal Sepsis. Case Med Res 2019 https://clinicaltrials.gov/ct2/show/NCT03880305
8. Koltsova E.M., Balandina A.N., Grischuk K.I., Shpilyuk M.A., Dashkevich N.M., Poletaev A.V. et al. The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery. J Perinat Med 2018; 46:251–260. DOI: 10.1515/jpm-2016-0333
9. Khan A.O., Pike J.A. Super-resolution imaging and quantification of megakaryocytes and platelets. Platelets 2020; 1: 1–11. DOI: 10.1080/09537104.2020.1732321
10. Krapivina E.V., Novikova T.V. Functional features of hemostasis in physically weakened newborn piglets and calves. BIO Web of Conferences 2020; 17: 1-5. DOI: 10.1051/bioconf/20201700162
11. Ngo A.T.P., Sheriff J., Rocheleau A.D., Bucher M., Jones K.R., Sepp A.L.I. et al. Assessment of neonatal, cord, and adult platelet granule trafficking and secretion. Platelets 2020; 31(1): 68–78. DOI: 10.1080/09537104.2019.1573314
12. Cott E.V., Smock K., Lippi G. Innovations in Thrombosis and Hemostasis: A Glimpse Towards the Future of Diagnostic Analyzers. Sem Thromb Hemost 2019; 45(3): 225–227. DOI: 10.1055/s-0039-1683844
13. Ferrer-Marin F., Liu Z.J., Gutti R., Sola-Visner M. Neonatal Thrombocytopenia and Megakaryocytopoiesis. Semin Hematol 2010; 47: 281–8. DOI: 10.1053/j.seminhema-tol.2010.04.002
14. Meyer A.D., Rishmawi A.R., Kamucheka R., Lafleur C., Batchinsky A.I., Mackman N. et al. Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulation. J Thromb Haemost 2020; 18(2): 399–410. DOI: 10.1111/jth.14661
15. Urban D., Pluthero F., Christensen H., Baidya Sh., Rand M., Das A. et al. Decreased numbers of dense granules in fetal and neonatal platelets. Haematol 2017; 102:e36–8. DOI: 10.3324/haematol.2016.152421
16. Sitaru A.G., Holzhauer S., Speer C.P., Singer D., Obergfell A., Walter U., Grossmann R. Neonatal platelets from cord blood and peripheral blood. Platelets 2005; 16:203–10. DOI: org/10.1080/09537100400016862
17. Haley K., Recht M., McCarty O. Neonatal platelets: mediators of primary hemostasis in the developing hemostatic system. Pediatr Res 2014; 76: 230–237. DOI: 10.1038/pr.2014.87
18. Monagle P. Slow progress. How do we shift the paradigm of thinking in pediatric thrombosis and anticoagulation? Thromb Res 2019; 173: 186–190. DOI: 10.1016/j.thromres.2018.07.016
19. Kenet G., Cohen O., Bajorat T., Nowak-Göttl U. Insights into neonatal thrombosis. Thromb Res 2019; 181: S33–S36. DOI: 10.1016/s0049-3848(19)30364-0
20. Federici E., Al-Mondhiry H. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A. Thromb Res 2019; 182:75–78. DOI: 10.1016/j.thromres.2019.07.030
21. Черкасова С.В. Гемостаз новорожденных. Практика педиатра 2020; 1:49–52. [Cherkasova S.V. Hemostasis of the newborn. Praktika pediatra 2020; 1:49–52. (in Russ.)]
22. Heavey E. Screening newborns for critical congenital heart defects. Nursing 2019; 49(1):17–18. DOI: 10.1097/01.nurse.0000549738.60681.f8
23. Koltsova E.M., Balashova E.N., Ignatova A.A., Poletaev A.V., Polokhov D.M., Kuprash A.D. et al. Impaired platelet activity and hypercoagulation in healthy term and moderately preterm newborns during the early neonatal period. Pediatr Res 2019; 85:63–71. DOI: 10.1038/s41390-018-0184-8
24. Yurdakök K., Oran O., Tekinalp G., Dündar S., Yurdakök M. Plasma Protein C and Antithrombin III Levels in Polycythemic Newborns. J Pediatr Hematol Oncol 1989; 6(1):59–61. DOI: 10.3109/08880018909014583
25. Marco A., Marco P. Cerebral Venous Thrombosis in a Pediatric Patient with Antithrombin Deficiency. J Clinical Case Rep Case Stud 2019; 2(1):16–20. DOI: 10.29199/2637-9309/cccs.201020
26. Koltsova E.M., Balandina A.N., Grischuk K.I., Shpilyuk M.A., Seregina E.A., Dashkevich N.M. et al. The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery. J Perinat Med 2017; 46(3):251–260. DOI: 10.1515/jpm-2016-0333
27. Nowak-Göttl U., Limperger V., Kenet G., Degenhardt F., Arlt R., Domschikowski J. et al. Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67: 2–13. DOI: 10.1016/j.bcmd.2016.11.012
28. Lokeshwar M.R., Sachdeva A. Fetal & Neonatal Hematology, Oncology and Immunology. London, Jaypee Brothers Medical Publishers; first edition. 2017; 135–137
29. Lee J.W., Her S.M., Kim J.H., Lee K.H., Eisenhut M., Park S.J., Shin J.I. D-dimer as a marker of acute pyelonephritis in infants younger than 24 months with urinary tract infection. Pediatr Nephrol 2018; 33(4):631–637. DOI: 10.1007/s00467-017-3843-9
30. Asakura H., Takahashi H., Uchiyama T., Eguchi Y., Okamoto K., Kawasugi K. et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thrombosis J 2016; 14(1): 42. DOI: 10.1186/s12959-016-0117-x
31. Sharma A. Plasma Fibrinogen and D-dimer in Children With Sepsis: A Single-Center Experience. Iran J Pathol 2018; 13(2):272–275. DOI: 10.30699/ijp.13.2.272
32. Stefanov G., Puppala B.L., Pais G., Gulati A. Endothelin-1 levels, and renal function in newborns of various gestational ages. J Neonatal Perinatal Med 2016; 9:145–152. DOI: 10.3233/NPM-16915078
33. El Shemi M.S., Tawfik S., Khafagy S.M., Hamza M.T., Youssef A.M.A. Endothelin 1 as a predictor marker for bronchopulmonary dysplasia in preterm neonates with respiratory distress syndrome. J Neonatal Perinatal Med 2017; 10:79–83. DOI: 10.3233/NPM-1653
34. Sewell E.K., Forman K.R., Wong E.C.C., Gallagher M., Luban N.L.C., Massaro A.N. Thromboelastography in term neonates: an alternative approach to evaluating coagulopathy. Arch Dis Child Fetal Neonatal Ed 2017; 102: F79–84. DOI: 10.1136/archdischild-2016-310545
35. Gracheva M.A., Urnova E.S., Sinauridze E.I., Tarandovskiy I.D., Orel E.B., Poletaev A.V. et al. Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma. Leuk Lymphoma 2015; 56: 3418–3425. DOI: 10.3109/10428194.2015.1041385
36. Koltsova E.M., Balashova E.N., Panteleev M.A., Balandina A.N. Laboratory aspects of hemostasis in neonates. Pediatr Hematol Oncol Immunopathol 2018; 17(4): 100–113. DOI: 10.24287/1726-1708-2018-17-4-100-113
37. Strauss T., Elisha N., Ravid B., Rosenberg N., Lubetsky A., Levy-Mendelovich S. et al. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full-term neonates, Blood Cell Mol Dis 2017; 67: 14–17. DOI: 10.1016/j.bcmd.2016.12.013
38. Mutch N.J., Koikkalainen J.S., Fraser S.R., Duthie K.M., Griffin M., Mitchell J. et al. Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis. J Thromb Haemost 2010; 8(9): 2017–24. DOI: 10.1111/j.1538-7836.2010.03963.x
39. Bhat R., Monagle P. Anticoagulation in preterm and term neonates: Why are they special? Thromb Res 2020; 187: 113– 121. DOI: 10.1016/j.thromres.2019.12.019
40. Baker-Groberg S.M., Lattimore S., Recht M., McCarty O.J.T., Haley K.M. Assessment of neonatal platelet adhesion, activation, and aggregation. J Thromb Haemost 2016; 14: 815–827. DOI: 10.1111/jth.13270
41. Кольцова Е.М., Балашова Е.Н., Пантелеев М.А., Баландина А.Н. Лабораторные аспекты гемостаза новорожденных. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2018; 17(4): 100–113. [Kol’cova E.M., Balashova E.N., Panteleev M.A., Balandina A.N. Laboratory aspects of hemostasis in newborns. Voprosy gematologii/onkologii i immunopatologii v pediatrii 2018; 17(4): 100–113. (in Russ.)]
42. Abentaeva B., Charipova B., Aubakirova B. Clinical case neonatal thrombosis of preterm newborn. J Cllin Med Kaz 2017; 3(45):84–88. DOI: 10.23950/1812-2892-JCMK-00481
43. Darwood R., Berridge D.C., Kessel D.O., Robertson I., Forster R. Surgery versus thrombolysis for initialmanagement of acute limb ischaemia. Cochrane Database Syst Rev 2018; 8: CD002784. DOI: 10.1002/14651858.CD002784.pub3
44. Федеральные клинические рекомендации по диагностике, профилактике и лечению тромбозов у детей и подростков. ФГБУ «ФНКЦ ДГОИ имени Дмитрия Рогачева» Минздрава России и Национальное общество детских гематологов, онкологов России 2015 г. [Federal clinical guidelines for the diagnosis, prevention and treatment of thrombosis in children and adolescents. FSBI “FNKTS DPOI named after Dmitry Rogachev” of the Ministry of Health of Russia and the National Society of Pediatric Hematologists, Oncologists of Russia 2015; http://nodgo.org/sites/default/files/34.%20Тромбозы.pdf]
45. Moustafa F., Pesavento R., Micco P.D., González-Martínez J., Quintavalla R., Peris M.l. et al. Real-life use of anticoagulants in venous thromboembolism, with focus on patients with exclusion criteria for direct oral anticoagulants. Clin. Pharmacol. Ther. 2018; 103: 684–691. DOI: 10.1002/cpt.781
46. Monagle P., Cuello C.A., Augustine C., Bonduel M., Brandão L.R., Capman T. et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2018; 2: 3292–3316. DOI: 10.1182/bloodadvances.2018024786
47. Iijima S. Seasonal and meteorological associations of vitamin K-dependent coagulation factors in 1-month-old infants. Blood Coagul Fibrinols 2020; 31(3): 233–236. DOI: 10.1097/mbc.0000000000000896
48. Brett O.F., Brett C.N., Chin P.K.L. The effect of routine preoperative interruption of dabigatran therapy on coagulation parameters and dabigatran plasma levels in a mixed surgical population. Anaesth Intens Care 2019; 47(2): 183–188. DOI: 10.1177/0310057x19841009
49. Dieffenbach B. V., Nath B.D., Tracy E.T., Kim H.B. Management of symptomatic neonatal aortic thrombosis: When is surgery indicated? J Pediatr Surg Case Rep 2019; 47: 1–4. DOI: 10.1016/j.epsc.2019.101247
50. Utne K.K., Dahm A., Wik H.S., Jelsness-Jørgensen L.P., Sandset P.M., Ghanima W. Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome. Thromb Res 2018; 163: 6–11. DOI: 10.1016/j.thromres.2018.01.013
51. Houghton D.E., Casanegra A., Peterson L.G., Cochuyt J., Hodge D.O., Vlazny D. et al. Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban. Blood 2019; 134(1): 2158. DOI: 10.1182/blood-2019-125099
52. Mantis C., Alexopoulos D. Antithrombotic treatment in atrial fibrillation patients undergoing PCI: Is dual therapy the winner? Thromb Res 2019; 176: 133–139. DOI: 10.1016/j.thromres.2019.02.022
53. Sol J.S., Loo M., Boerma M., Bergman K.A., Donker A.E., van der Hoeven M.A. et al. NEOnatal Central-venous Line Observational study on Thrombosis (NEOCLOT): evaluation of a national guideline on management of neonatal catheter-related thrombosis. BMC Pediatr 2018; 18(1): 84. DOI: 10.1186/s12887-018-1000-7
54. Аксенов Д.В., Чусов К.П., Рябкова М.Г., Свирин П.В., Кругляков А.Ю., Дубенок С.Ю. Тромболитическая терапия у новорожденного с массивным артериовенозным тромбозом. Опыт Морозовской детской городской клинической больницы. Неонатология: новости, мнения, обучение 2019; 7(2): 59–67. [Aksenov D.V., Chusov K.P., Ryabkova M.G., Svirin P.V., Kruglyakov A.Yu., Dubenok S.Yu. Thrombolytic therapy in a newborn with massive arteriovenous thrombosis. Experience of the Morozov Children’s City Clinical Hospital. Neonatologiya: novosti, mneniya, obuche- nie 2019; 7(2): 59–67. (in Russ.)]
55. Puangpunngam N. Endovascular thrombectomy versus open surgical thrombectomy for thrombosed arteriovenous hemodialysis graft. Siriraj Med J 2019; 71(6): 491–498. DOI: 10.33192/smj.2019.73
56. Cournoyer-Rodrigue J., Bui T.B., Gilbert P., Soulez G., Perreault P., Bouchard L. et al. Percutaneous Thrombectomy with the JETi8 Peripheral Thrombectomy System for the Treatment of Deep Vein Thrombosis. J Vascular and Interventional Radiology 2020; 31(3): 444–453. DOI: org/10.1016/j.jvir.2019.10.022
57. Nurmeev I.N., Kostromin A.A., Okoye B. Treatment of the newborn with a floating thrombus in the right atrium: case report. Russ Open Med J 2019; 8:e0111
58. Dieffenbach B. V., Nath B.D., Tracy E.T., Kim H.B. Management of symptomatic neonatal aortic thrombosis: When is surgery indicated? J Pediatr Surg Case Rep 2019; 47: 1–4. DOI: 10.1016/j.epsc.2019.101247
59. Ivlev D.A., Shirinli S.N., Guria K.G., Uzlova S.G., Guria G.T. Control of fibrinolytic drug injection via real-time ultrasonic monitoring of blood coagulation. PLOS ONE 2019: 1–17. DOI: 10.1371/journal.pone.0211646
Review
For citations:
Bairashevskaya A.V., Kytko O.V. Neonatal thrombosis: causes, pathogenesis, treatment features. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2021;66(2):21-28. (In Russ.) https://doi.org/10.21508/1027-4065-2021-66-2-21-28
Views:
1247
Email this article 